Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant
Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus , which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In...
Saved in:
Published in | Journal of virology Vol. 93; no. 13 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.07.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Feline leukemia virus (FeLV) is a member of the genus
Gammaretrovirus
, which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the
env
gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses.
Feline leukemia virus (FeLV) is horizontally transmitted among cats and causes a variety of hematopoietic disorders. Five subgroups of FeLV, A to D and T, each with distinct receptor usages, have been described. Recently, we identified a new FeLV Env (TG35-2) gene from a pseudotyped virus that does not belong to any known subgroup. FeLV-A is the primary virus from which other subgroups have emerged via mutation or recombination of the subgroup A
env
gene. Retrovirus entry into cells is mediated by the interaction of envelope protein (Env) with specific cell surface receptors. Here, phenotypic screening of a human/hamster radiation hybrid panel identified SLC19A1, a feline reduced folate carrier (RFC) and potential receptor for TG35-2-phenotypic virus. RFC is a multipass transmembrane protein. Feline and human RFC cDNAs conferred susceptibility to TG35-2-pseudotyped virus when introduced into nonpermissive cells but did not render these cells permissive to other FeLV subgroups or feline endogenous retrovirus. Moreover, human cells with genomic deletion of RFC were nonpermissive for TG35-2-pseudotyped virus infection, but the introduction of feline and human cDNAs rendered them permissive. Mutation analysis of FeLV Env demonstrated that amino acid substitutions within variable region A altered the specificity of the Env-receptor interaction. We isolated and reconstructed the full-length infectious TG35-2-phenotypic provirus from a naturally FeLV-infected cat, from which the FeLV Env (TG35-2) gene was previously isolated, and compared the replication of the virus in hematopoietic cell lines with that of FeLV-A 61E by measuring the viral RNA copy numbers. These results provide a tool for further investigation of FeLV infectious disease.
IMPORTANCE
Feline leukemia virus (FeLV) is a member of the genus
Gammaretrovirus
, which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the
env
gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses. |
---|---|
AbstractList | Feline leukemia virus (FeLV) is horizontally transmitted among cats and causes a variety of hematopoietic disorders. Five subgroups of FeLV, A to D and T, each with distinct receptor usages, have been described. Recently, we identified a new FeLV Env (TG35-2) gene from a pseudotyped virus that does not belong to any known subgroup. FeLV-A is the primary virus from which other subgroups have emerged via mutation or recombination of the subgroup A
gene. Retrovirus entry into cells is mediated by the interaction of envelope protein (Env) with specific cell surface receptors. Here, phenotypic screening of a human/hamster radiation hybrid panel identified SLC19A1, a feline reduced folate carrier (RFC) and potential receptor for TG35-2-phenotypic virus. RFC is a multipass transmembrane protein. Feline and human RFC cDNAs conferred susceptibility to TG35-2-pseudotyped virus when introduced into nonpermissive cells but did not render these cells permissive to other FeLV subgroups or feline endogenous retrovirus. Moreover, human cells with genomic deletion of RFC were nonpermissive for TG35-2-pseudotyped virus infection, but the introduction of feline and human cDNAs rendered them permissive. Mutation analysis of FeLV Env demonstrated that amino acid substitutions within variable region A altered the specificity of the Env-receptor interaction. We isolated and reconstructed the full-length infectious TG35-2-phenotypic provirus from a naturally FeLV-infected cat, from which the FeLV Env (TG35-2) gene was previously isolated, and compared the replication of the virus in hematopoietic cell lines with that of FeLV-A 61E by measuring the viral RNA copy numbers. These results provide a tool for further investigation of FeLV infectious disease.
Feline leukemia virus (FeLV) is a member of the genus
, which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the
gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses. Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus , which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the env gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses. Feline leukemia virus (FeLV) is horizontally transmitted among cats and causes a variety of hematopoietic disorders. Five subgroups of FeLV, A to D and T, each with distinct receptor usages, have been described. Recently, we identified a new FeLV Env (TG35-2) gene from a pseudotyped virus that does not belong to any known subgroup. FeLV-A is the primary virus from which other subgroups have emerged via mutation or recombination of the subgroup A env gene. Retrovirus entry into cells is mediated by the interaction of envelope protein (Env) with specific cell surface receptors. Here, phenotypic screening of a human/hamster radiation hybrid panel identified SLC19A1, a feline reduced folate carrier (RFC) and potential receptor for TG35-2-phenotypic virus. RFC is a multipass transmembrane protein. Feline and human RFC cDNAs conferred susceptibility to TG35-2-pseudotyped virus when introduced into nonpermissive cells but did not render these cells permissive to other FeLV subgroups or feline endogenous retrovirus. Moreover, human cells with genomic deletion of RFC were nonpermissive for TG35-2-pseudotyped virus infection, but the introduction of feline and human cDNAs rendered them permissive. Mutation analysis of FeLV Env demonstrated that amino acid substitutions within variable region A altered the specificity of the Env-receptor interaction. We isolated and reconstructed the full-length infectious TG35-2-phenotypic provirus from a naturally FeLV-infected cat, from which the FeLV Env (TG35-2) gene was previously isolated, and compared the replication of the virus in hematopoietic cell lines with that of FeLV-A 61E by measuring the viral RNA copy numbers. These results provide a tool for further investigation of FeLV infectious disease. IMPORTANCE Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus , which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the env gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses. Feline leukemia virus (FeLV) is horizontally transmitted among cats and causes a variety of hematopoietic disorders. Five subgroups of FeLV, A to D and T, each with distinct receptor usages, have been described. Recently, we identified a new FeLV Env (TG35-2) gene from a pseudotyped virus that does not belong to any known subgroup. FeLV-A is the primary virus from which other subgroups have emerged via mutation or recombination of the subgroup A env gene. Retrovirus entry into cells is mediated by the interaction of envelope protein (Env) with specific cell surface receptors. Here, phenotypic screening of a human/hamster radiation hybrid panel identified SLC19A1, a feline reduced folate carrier (RFC) and potential receptor for TG35-2-phenotypic virus. RFC is a multipass transmembrane protein. Feline and human RFC cDNAs conferred susceptibility to TG35-2-pseudotyped virus when introduced into nonpermissive cells but did not render these cells permissive to other FeLV subgroups or feline endogenous retrovirus. Moreover, human cells with genomic deletion of RFC were nonpermissive for TG35-2-pseudotyped virus infection, but the introduction of feline and human cDNAs rendered them permissive. Mutation analysis of FeLV Env demonstrated that amino acid substitutions within variable region A altered the specificity of the Env-receptor interaction. We isolated and reconstructed the full-length infectious TG35-2-phenotypic provirus from a naturally FeLV-infected cat, from which the FeLV Env (TG35-2) gene was previously isolated, and compared the replication of the virus in hematopoietic cell lines with that of FeLV-A 61E by measuring the viral RNA copy numbers. These results provide a tool for further investigation of FeLV infectious disease.IMPORTANCE Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus, which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the env gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses.Feline leukemia virus (FeLV) is horizontally transmitted among cats and causes a variety of hematopoietic disorders. Five subgroups of FeLV, A to D and T, each with distinct receptor usages, have been described. Recently, we identified a new FeLV Env (TG35-2) gene from a pseudotyped virus that does not belong to any known subgroup. FeLV-A is the primary virus from which other subgroups have emerged via mutation or recombination of the subgroup A env gene. Retrovirus entry into cells is mediated by the interaction of envelope protein (Env) with specific cell surface receptors. Here, phenotypic screening of a human/hamster radiation hybrid panel identified SLC19A1, a feline reduced folate carrier (RFC) and potential receptor for TG35-2-phenotypic virus. RFC is a multipass transmembrane protein. Feline and human RFC cDNAs conferred susceptibility to TG35-2-pseudotyped virus when introduced into nonpermissive cells but did not render these cells permissive to other FeLV subgroups or feline endogenous retrovirus. Moreover, human cells with genomic deletion of RFC were nonpermissive for TG35-2-pseudotyped virus infection, but the introduction of feline and human cDNAs rendered them permissive. Mutation analysis of FeLV Env demonstrated that amino acid substitutions within variable region A altered the specificity of the Env-receptor interaction. We isolated and reconstructed the full-length infectious TG35-2-phenotypic provirus from a naturally FeLV-infected cat, from which the FeLV Env (TG35-2) gene was previously isolated, and compared the replication of the virus in hematopoietic cell lines with that of FeLV-A 61E by measuring the viral RNA copy numbers. These results provide a tool for further investigation of FeLV infectious disease.IMPORTANCE Feline leukemia virus (FeLV) is a member of the genus Gammaretrovirus, which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV subgroup A (FeLV-A), and specific binding of FeLV-A Env to its viral receptor, thiamine transporter feTHTR1, is the first step of infection. In infected cats, novel variants of FeLV with altered receptor specificity for viral entry have emerged by mutation or recombination of the env gene. A novel FeLV variant arose from a subtle mutation of FeLV-A Env, which altered the specific interaction of the virus with its receptor. RFC, a folate transporter, is a potential receptor for the novel FeLV variant. The perturbation of specific retrovirus-receptor interactions under selective pressure by the host results in the emergence of novel viruses. |
Author | Kawasaki, Junna Miyake, Ariko Muto, Yutaro Khan, Arshad H. Ngo, Ha Nishigaki, Kazuo Smith, Desmond J. Makundi, Isaac |
Author_xml | – sequence: 1 givenname: Ariko surname: Miyake fullname: Miyake, Ariko organization: Laboratory of Molecular Immunology and Infectious Disease, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan – sequence: 2 givenname: Junna surname: Kawasaki fullname: Kawasaki, Junna organization: Laboratory of Molecular Immunology and Infectious Disease, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan – sequence: 3 givenname: Ha surname: Ngo fullname: Ngo, Ha organization: The United Graduate School of Veterinary Science, Yamaguchi University, Yamaguchi, Japan – sequence: 4 givenname: Isaac surname: Makundi fullname: Makundi, Isaac organization: The United Graduate School of Veterinary Science, Yamaguchi University, Yamaguchi, Japan – sequence: 5 givenname: Yutaro surname: Muto fullname: Muto, Yutaro organization: Laboratory of Molecular Immunology and Infectious Disease, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan – sequence: 6 givenname: Arshad H. surname: Khan fullname: Khan, Arshad H. organization: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA – sequence: 7 givenname: Desmond J. surname: Smith fullname: Smith, Desmond J. organization: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA – sequence: 8 givenname: Kazuo surname: Nishigaki fullname: Nishigaki, Kazuo organization: Laboratory of Molecular Immunology and Infectious Disease, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan, The United Graduate School of Veterinary Science, Yamaguchi University, Yamaguchi, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30996094$$D View this record in MEDLINE/PubMed |
BookMark | eNptkctL7TAQxoMoenzs7vqSpQurSZq0jQtBDh4fHBR8HNyFaTrVXHuaY9IK_vfWJ15xMQzM_OabYb51stz6Fgn5w9ku56LYO5ud7jImMp1wvURGnOkiUYrLZTIayiJRaXG7RtZj_McYlzKTq2QtZVpnTMsRubrEqrdY0YlvoEM6hhAchn0KLT1qu_BML9HiovOB1kMAPfdP2NAJNq5FOsX-AecO6MyFPtIZBAdtt0lWamgibn3kDXIzOboenyTTi-PT8eE0sVKxLlEiE7KwFQihsSytLfO8wqzOOSotBWSgaw5al5UsFWqbV8ALUZWyFKKGXKUb5OBdd9GXc6wsDvdCYxbBzSE8Gw_O_N9p3b25808mUwXTeToIbH8IBP_YY-zM3EWLTQMt-j4aIThPRSFYPqB_v-_6WvL5yQHYeQds8DEGrL8QzsyrUWYwyrwZZbgecPEDt66DzvnXS13z-9ALpMKW1Q |
CitedBy_id | crossref_primary_10_1073_pnas_2114441119 crossref_primary_10_1128_jvi_01771_23 crossref_primary_10_1128_jvi_00229_22 crossref_primary_10_1128_JVI_02136_20 crossref_primary_10_1016_j_cvsm_2020_05_006 crossref_primary_10_3390_vetsci9090467 crossref_primary_10_1128_jvi_01400_23 |
Cites_doi | 10.1038/tpj.2015.50 10.1073/pnas.1304704110 10.1038/sj.gt.3301206 10.1128/jvi.71.12.9823-9827.1997 10.1128/jvi.66.2.1219-1222.1992 10.1158/1078-0432.CCR-1066-03 10.1128/MMBR.00044-17 10.1002/ijc.2910210411 10.1128/jvi.67.6.3118-3125.1993 10.1128/jvi.52.2.695-698.1984 10.1007/s10555-007-9046-2 10.1093/oxfordjournals.molbev.a040454 10.1186/1471-2164-12-562 10.1016/j.jviromet.2005.06.017 10.1073/pnas.130200097 10.1128/jvi.65.8.4461-4469.1991 10.1016/j.virusres.2015.04.008 10.1128/JVI.75.22.10563-10572.2001 10.1128/jvi.58.3.825-834.1986 10.1128/jvi.66.3.1635-1640.1992 10.7554/eLife.22519 10.1128/JVI.00280-12 10.1007/BF02624087 10.1128/JVI.72.4.2686-2696.1998 10.1016/0042-6822(71)90266-2 10.1002/ijc.2910210314 10.1128/jvi.46.3.871-880.1983 10.1038/275656a0 10.1128/JVI.79.3.1351-1360.2005 10.1002/ijc.24050 10.1186/1742-4690-2-52 10.1016/j.mam.2012.07.006 10.1128/JVI.80.4.1619-1628.2006 10.1128/JVI.01385-13 10.1128/JVI.02317-08 10.1128/JVI.76.3.1527-1532.2002 10.1093/nar/gkh340 10.1101/gr.7.5.422 10.1534/genetics.114.167916 10.1016/0092-8674(89)90134-7 10.1128/jvi.49.2.629-632.1984 10.1126/science.287.5459.1828 10.1016/j.vetimm.2010.12.010 10.1073/pnas.1012344107 10.1128/JVI.80.6.3104-3107.2006 10.1016/0042-6822(92)90924-E 10.1128/JVI.73.8.6500-6505.1999 10.1128/jvi.62.3.722-731.1988 10.1128/JVI.03229-15 10.1073/pnas.89.18.8457 10.3390/v4112684 10.1182/blood.V95.3.1093.003k01_1093_1099 10.1093/molbev/msw054 10.1099/0022-1317-20-2-169 10.1128/JVI.01125-18 10.3390/v7010001 10.1371/journal.pone.0061009 10.1099/0022-1317-73-11-2839 10.1128/jvi.71.6.4531-4535.1997 10.1128/jvi.68.12.8296-8303.1994 10.1128/JVI.80.7.3378-3385.2006 10.1074/jbc.M607049200 10.3390/v10010029 10.1126/science.2893454 10.1111/j.1558-5646.1985.tb00420.x 10.1128/JVI.01267-13 10.1128/JVI.00716-16 10.1093/oxfordjournals.aje.a118408 10.1007/BF02618435 |
ContentType | Journal Article |
Copyright | Copyright © 2019 American Society for Microbiology. Copyright © 2019 American Society for Microbiology. 2019 American Society for Microbiology |
Copyright_xml | – notice: Copyright © 2019 American Society for Microbiology. – notice: Copyright © 2019 American Society for Microbiology. 2019 American Society for Microbiology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1128/JVI.00269-19 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Receptor for Novel FeLV Variant |
EISSN | 1098-5514 |
ExternalDocumentID | PMC6580973 30996094 10_1128_JVI_00269_19 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHGRI NIH HHS grantid: R21 HG007405 – fundername: ; grantid: R21 HG007405 – fundername: ; grantid: 15H04602 |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAFWJ AAGFI AAYJJ AAYXX ABPPZ ACGFO ACNCT ADBBV ADXHL AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CITATION CS3 D0S DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A O9- OHT OK1 P2P RHI RNS RPM RSF TR2 UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c450t-526248cda229ebbccb77de6f71e5942a6a9f1a99bd4b5e9c7da182db4b22fa753 |
ISSN | 0022-538X 1098-5514 |
IngestDate | Thu Aug 21 13:57:42 EDT 2025 Fri Jul 11 07:53:11 EDT 2025 Mon Jul 21 06:03:06 EDT 2025 Thu Apr 24 23:12:00 EDT 2025 Tue Jul 01 01:03:01 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 13 |
Keywords | viral pathogenesis viral envelope cats viral infection endogenous retrovirus viral receptor feline leukemia virus retroviruses |
Language | English |
License | Copyright © 2019 American Society for Microbiology. All Rights Reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c450t-526248cda229ebbccb77de6f71e5942a6a9f1a99bd4b5e9c7da182db4b22fa753 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 A.M., J.K., and H.N. contributed equally to this work. Citation Miyake A, Kawasaki J, Ngo H, Makundi I, Muto Y, Khan AH, Smith DJ, Nishigaki K. 2019. Reduced folate carrier: an entry receptor for a novel feline leukemia virus variant. J Virol 93:e00269-19. https://doi.org/10.1128/JVI.00269-19. |
OpenAccessLink | https://jvi.asm.org/content/jvi/93/13/e00269-19.full.pdf |
PMID | 30996094 |
PQID | 2211328207 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6580973 proquest_miscellaneous_2211328207 pubmed_primary_30996094 crossref_primary_10_1128_JVI_00269_19 crossref_citationtrail_10_1128_JVI_00269_19 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-07-01 |
PublicationDateYYYYMMDD | 2019-07-01 |
PublicationDate_xml | – month: 07 year: 2019 text: 2019-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2019 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_49_2 Hardy WD (e_1_3_2_22_2) 1976; 36 e_1_3_2_41_2 e_1_3_2_64_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_62_2 e_1_3_2_45_2 e_1_3_2_68_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_66_2 e_1_3_2_60_2 e_1_3_2_9_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_54_2 e_1_3_2_75_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_52_2 e_1_3_2_73_2 e_1_3_2_5_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_58_2 e_1_3_2_14_2 e_1_3_2_35_2 e_1_3_2_56_2 e_1_3_2_50_2 Hunter E (e_1_3_2_3_2) 1997 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_65_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_63_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_69_2 e_1_3_2_25_2 e_1_3_2_67_2 O'Hara B (e_1_3_2_28_2) 1990; 1 e_1_3_2_61_2 Rasheed S (e_1_3_2_46_2) 1980 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_59_2 e_1_3_2_6_2 e_1_3_2_19_2 Jones DT (e_1_3_2_71_2) 1992; 8 e_1_3_2_30_2 e_1_3_2_53_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_74_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_57_2 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_55_2 e_1_3_2_2_2 e_1_3_2_72_2 e_1_3_2_70_2 |
References_xml | – ident: e_1_3_2_39_2 doi: 10.1038/tpj.2015.50 – ident: e_1_3_2_61_2 doi: 10.1073/pnas.1304704110 – ident: e_1_3_2_64_2 doi: 10.1038/sj.gt.3301206 – ident: e_1_3_2_14_2 doi: 10.1128/jvi.71.12.9823-9827.1997 – ident: e_1_3_2_30_2 doi: 10.1128/jvi.66.2.1219-1222.1992 – ident: e_1_3_2_41_2 doi: 10.1158/1078-0432.CCR-1066-03 – ident: e_1_3_2_2_2 doi: 10.1128/MMBR.00044-17 – ident: e_1_3_2_23_2 doi: 10.1002/ijc.2910210411 – ident: e_1_3_2_12_2 doi: 10.1128/jvi.67.6.3118-3125.1993 – ident: e_1_3_2_63_2 doi: 10.1128/jvi.52.2.695-698.1984 – ident: e_1_3_2_52_2 doi: 10.1007/s10555-007-9046-2 – ident: e_1_3_2_70_2 doi: 10.1093/oxfordjournals.molbev.a040454 – ident: e_1_3_2_38_2 doi: 10.1186/1471-2164-12-562 – volume: 36 start-page: 582 year: 1976 ident: e_1_3_2_22_2 article-title: Biology of feline leukemia virus in the natural environment publication-title: Cancer Res – ident: e_1_3_2_74_2 doi: 10.1016/j.jviromet.2005.06.017 – ident: e_1_3_2_36_2 doi: 10.1073/pnas.130200097 – ident: e_1_3_2_21_2 doi: 10.1128/jvi.65.8.4461-4469.1991 – ident: e_1_3_2_51_2 doi: 10.1016/j.virusres.2015.04.008 – ident: e_1_3_2_31_2 doi: 10.1128/JVI.75.22.10563-10572.2001 – ident: e_1_3_2_43_2 doi: 10.1128/jvi.58.3.825-834.1986 – ident: e_1_3_2_29_2 doi: 10.1128/jvi.66.3.1635-1640.1992 – ident: e_1_3_2_54_2 doi: 10.7554/eLife.22519 – ident: e_1_3_2_18_2 doi: 10.1128/JVI.00280-12 – ident: e_1_3_2_47_2 doi: 10.1007/BF02624087 – ident: e_1_3_2_20_2 doi: 10.1128/JVI.72.4.2686-2696.1998 – ident: e_1_3_2_16_2 doi: 10.1016/0042-6822(71)90266-2 – ident: e_1_3_2_24_2 doi: 10.1002/ijc.2910210314 – ident: e_1_3_2_25_2 doi: 10.1128/jvi.46.3.871-880.1983 – ident: e_1_3_2_48_2 doi: 10.1038/275656a0 – ident: e_1_3_2_15_2 doi: 10.1128/JVI.79.3.1351-1360.2005 – ident: e_1_3_2_8_2 doi: 10.1002/ijc.24050 – ident: e_1_3_2_4_2 doi: 10.1186/1742-4690-2-52 – ident: e_1_3_2_44_2 doi: 10.1016/j.mam.2012.07.006 – ident: e_1_3_2_60_2 doi: 10.1128/JVI.80.4.1619-1628.2006 – ident: e_1_3_2_62_2 doi: 10.1128/JVI.01385-13 – ident: e_1_3_2_34_2 doi: 10.1128/JVI.02317-08 – ident: e_1_3_2_42_2 doi: 10.1128/JVI.76.3.1527-1532.2002 – ident: e_1_3_2_69_2 doi: 10.1093/nar/gkh340 – ident: e_1_3_2_37_2 doi: 10.1101/gr.7.5.422 – ident: e_1_3_2_40_2 doi: 10.1534/genetics.114.167916 – ident: e_1_3_2_55_2 doi: 10.1016/0092-8674(89)90134-7 – ident: e_1_3_2_66_2 doi: 10.1128/jvi.49.2.629-632.1984 – ident: e_1_3_2_35_2 doi: 10.1126/science.287.5459.1828 – ident: e_1_3_2_49_2 doi: 10.1016/j.vetimm.2010.12.010 – ident: e_1_3_2_53_2 doi: 10.1073/pnas.1012344107 – ident: e_1_3_2_58_2 doi: 10.1128/JVI.80.6.3104-3107.2006 – start-page: 393 volume-title: Proceedings of the third international feline leukemia virus meeting year: 1980 ident: e_1_3_2_46_2 – ident: e_1_3_2_26_2 doi: 10.1016/0042-6822(92)90924-E – ident: e_1_3_2_32_2 doi: 10.1128/JVI.73.8.6500-6505.1999 – ident: e_1_3_2_50_2 doi: 10.1128/jvi.62.3.722-731.1988 – ident: e_1_3_2_19_2 doi: 10.1128/JVI.03229-15 – start-page: 71 volume-title: Retroviruses year: 1997 ident: e_1_3_2_3_2 – ident: e_1_3_2_10_2 doi: 10.1073/pnas.89.18.8457 – ident: e_1_3_2_7_2 doi: 10.3390/v4112684 – ident: e_1_3_2_33_2 doi: 10.1182/blood.V95.3.1093.003k01_1093_1099 – volume: 1 start-page: 119 year: 1990 ident: e_1_3_2_28_2 article-title: Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus publication-title: Cell Growth Differ – ident: e_1_3_2_68_2 doi: 10.1093/molbev/msw054 – volume: 8 start-page: 275 year: 1992 ident: e_1_3_2_71_2 article-title: The rapid generation of mutation data matrices from protein sequences publication-title: Comput Appl Biosci – ident: e_1_3_2_17_2 doi: 10.1099/0022-1317-20-2-169 – ident: e_1_3_2_57_2 doi: 10.1128/JVI.01125-18 – ident: e_1_3_2_56_2 doi: 10.3390/v7010001 – ident: e_1_3_2_6_2 doi: 10.1371/journal.pone.0061009 – ident: e_1_3_2_11_2 doi: 10.1099/0022-1317-73-11-2839 – ident: e_1_3_2_59_2 doi: 10.1128/jvi.71.6.4531-4535.1997 – ident: e_1_3_2_13_2 doi: 10.1128/jvi.68.12.8296-8303.1994 – ident: e_1_3_2_27_2 doi: 10.1128/JVI.80.7.3378-3385.2006 – ident: e_1_3_2_75_2 doi: 10.1074/jbc.M607049200 – ident: e_1_3_2_5_2 doi: 10.3390/v10010029 – ident: e_1_3_2_9_2 doi: 10.1126/science.2893454 – ident: e_1_3_2_72_2 doi: 10.1111/j.1558-5646.1985.tb00420.x – ident: e_1_3_2_67_2 doi: 10.1128/JVI.01267-13 – ident: e_1_3_2_65_2 doi: 10.1128/JVI.00716-16 – ident: e_1_3_2_73_2 doi: 10.1093/oxfordjournals.aje.a118408 – ident: e_1_3_2_45_2 doi: 10.1007/BF02618435 |
SSID | ssj0014464 |
Score | 2.3665657 |
Snippet | Feline leukemia virus (FeLV) is a member of the genus
Gammaretrovirus
, which causes malignant diseases in cats. The most prevalent FeLV among cats is FeLV... Feline leukemia virus (FeLV) is horizontally transmitted among cats and causes a variety of hematopoietic disorders. Five subgroups of FeLV, A to D and T, each... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
SubjectTerms | Amino Acid Sequence Animals Cats Cell Line Cricetinae Endogenous Retroviruses - metabolism Gene Products, env - genetics Genes, env - genetics HeLa Cells Humans Leukemia Virus, Feline - genetics Leukemia Virus, Feline - metabolism Leukemia, Feline - virology Phylogeny Proviruses Receptors, Virus - genetics Receptors, Virus - metabolism Reduced Folate Carrier Protein - classification Reduced Folate Carrier Protein - genetics Reduced Folate Carrier Protein - metabolism RNA, Viral - genetics Sequence Alignment Viral Envelope Proteins - genetics Virus Internalization Virus Replication Virus-Cell Interactions |
Title | Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30996094 https://www.proquest.com/docview/2211328207 https://pubmed.ncbi.nlm.nih.gov/PMC6580973 |
Volume | 93 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKEGgviG_Kl4wET1GgcRyn4W2aVnUVrRBs1d4ix3FG1C2t-gEaD_zt3Nlxlo4hwV6iKnWTyr9fLndn3-8Ieas1vNaCfu4HMmI-F3ngZznHdJgoRCy4CoxuwXgihsd8dBKddDq_2tUl6-y9-nltXclNUIVzgCtWyf4Hss1F4QR8BnzhCAjD8Z8w_oK6q-AxDiA-XWvcvIH950z9cuUdYMsQdAv1AuJqu1vSm8y_6zNvoI1z-UlvZvq8lN60XG5W3hTCZllt5epb7irWw7Uz8OPyQtqNPXvLcjZvDLf8IVfS9sIegXPcWP3JqUnKDpsTYznbVLkZeLiSUrXzD6bkaWsvh1tYau8yHZeXKlJt64uBb2haCcO7xxpc1DNFr61tkW3PRMe88HpLz7B6YTQ9xJSYSHxreFugL84N6mEP9WdsI-Urytqfx_tAVNQrukVuMwgzmMv21KtQECpzpzaP_9sVTrD-h_aNd8ldd5dt7-aPkOXqztuWK3N0n9yrQaV7llAPSEdXD8kd25X04hH5WtOKWlrRmlYfqayoIRV1pKKAApXUkIpaUlFHKmpIRWtSPSbHg4Oj_aFf997wFY96az9igvG-yiVjic4ypbI4zrUo4kBHCWdSyKQIZJLAg51FOlFxLiFSzTOeMVZIiIGfkJ1qXulnhBasFwuVhAkXmmPRnIwiplGkNIyUyIsu8dycpaoWpsf-KGepCVBZP4XJTs1kp0HSJe-a0QsryPKXcW_c9KdgMXEZTFZ6vlmljAVByMDzjbvkqYWjuZLDsUviLaCaAajGvv1NVX4zquw1lZ7f-JcvyO7l8_WS7KyXG_0KPN519trQ8jer_KyI |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduced+Folate+Carrier%3A+an+Entry+Receptor+for+a+Novel+Feline+Leukemia+Virus+Variant&rft.jtitle=Journal+of+virology&rft.au=Miyake%2C+Ariko&rft.au=Kawasaki%2C+Junna&rft.au=Ngo%2C+Ha&rft.au=Makundi%2C+Isaac&rft.date=2019-07-01&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=93&rft.issue=13&rft_id=info:doi/10.1128%2FJVI.00269-19&rft_id=info%3Apmid%2F30996094&rft.externalDocID=PMC6580973 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |